Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
NCT05080010
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Retinoblastoma
Interventions
DRUG:
3 cycles chemotherapy
Sponsor
Sun Yat-sen University